Valiant Laboratories Ltd

NSE: VALIANTLAB · BSE: 543998 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹123.21
Market cap: ₹669.2 Cr
Revenue (annual): ₹237.5 Cr
Net profit (annual): ₹-3.27 Cr
P/E (TTM): 41.8×Sector 47.3×
Promoter holding: 74.94%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 3 Financial Results 3 Results Correction 2 Board Meeting Outcome 2 Board Meeting Date 2 Promoter Buying (Off-Market) 1 Merger & Restructuring 1 Legal & Regulatory 1 Fund Raise 1 Credit Rating 1 Annual Report 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

10 Aug 2026 20:32 IST NSE

Board Meeting Outcome

Valiant Laboratories Board Meeting Outcome

Valiant Laboratories approved the re-appointment of directors and a ₹60 Crore investment in its subsidiary, Valiant Advanced Sciences, alongside office relocation plans.

Value: ₹60.00 Cr

Read the filing ↗

14 May 2026 19:31 IST NSE

Board Meeting Outcome

Valiant Laboratories Board Meeting Outcome

Valiant Laboratories appointed Rajesh Chheda & Co. and Ketki D Visariya & Co. as auditors for FY 2026-27. The board meeting concluded on May 14, 2026.

Execution: FY 2026-27

Read the filing ↗